Novoeight recombinant and Paliperidone Extended-Release Tablets
Determining the interaction of Novoeight recombinant and Paliperidone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
Generic Name: paliperidone
Brand name: Invega, Invega Sustenna, Invega Trinza
Synonyms: Paliperidone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Novoeight recombinant-Paliperidone injection
- Novoeight recombinant-Paliperidone Intramuscular
- Novoeight recombinant-Palladone
- Novoeight recombinant-Palmitate-A
- Novoeight recombinant-Palonosetron
- Novoeight recombinant-Palonosetron Hydrochloride
- Paliperidone Extended-Release Tablets-Novolin 70/30
- Paliperidone Extended-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Paliperidone Extended-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Paliperidone Extended-Release Tablets-Novolin N
- Paliperidone Extended-Release Tablets-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Paliperidone Extended-Release Tablets-Novolin N (Insulin NPH (Vials))